Clinical exome sequencing data from patients with inborn errors of immunity: Cohort level diagnostic yield and the benefit of systematic reanalysis.
Vorsteveld EE, Van der Made CI, Smeekens SP, Schuurs-Hoeijmakers JH, Astuti G, Diepstra H, Gilissen C, Hoenselaar E, Janssen A, van Roozendaal K, Engelen JS, Steyaert W, Weiss MM, Yntema HG, Mantere T, AlZahrani MS, van Aerde K, Derfalvi B, Faqeih EA, Henriet SSV, van Hoof E, Idressi E, Issekutz TB, Jongmans MCJ, Keski-Filppula R, Krapels I, Te Loo M, Mulders-Manders CM, Ten Oever J, Potjewijd J, Sarhan NT, Slot MC, Terhal PA, Thijs H, Vandersteen A, Vanhoutte EK, van de Veerdonk F, van Well G, Netea MG; all members of the Radboud University Medical Center multidisciplinary immune-disease board; Simons A, Hoischen A; Radboud University Medical Center multidisciplinary immune-disease board; Arts RJW, Bijker EM, Bruno M, Hobo W, Hoppenreijs E, de Jonge MI, van Laarhoven A, van der Molen R, Oud M, Schatorje EJH, Smeets R, Sprenkeler EGG, Stol K, Verhagen LM, Zonneveld-Huijssoon E.
Vorsteveld EE, et al. Among authors: alzahrani ms.
Clin Immunol. 2024 Oct 4:110375. doi: 10.1016/j.clim.2024.110375. Online ahead of print.
Clin Immunol. 2024.
PMID: 39369972
Free article.